Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ALKS

Alkermes

$35.71

(0.00%)

09:47
11/30/18
11/30
09:47
11/30/18
09:47
Recommendations
Alkermes analyst commentary at Leerink »

Leerink sees commercial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 31

    Jan

ALKS

Alkermes

$37.45

0.58 (1.57%)

11:49
11/29/18
11/29
11:49
11/29/18
11:49
Recommendations
Alkermes analyst commentary at Goldman Sachs »

Goldman says questions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 02

    Dec

  • 31

    Jan

ALKS

Alkermes

$37.01

0.14 (0.38%)

11:25
11/29/18
11/29
11:25
11/29/18
11:25
Recommendations
Alkermes analyst commentary at Piper Jaffray »

Alkermes data support…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 02

    Dec

  • 31

    Jan

ALKS

Alkermes

$36.87

1.48 (4.18%)

09:12
11/29/18
11/29
09:12
11/29/18
09:12
Recommendations
Alkermes analyst commentary at Stifel »

Stifel sees Alkermes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 02

    Dec

  • 31

    Jan

ALKS

Alkermes

$36.87

1.48 (4.18%)

07:39
11/29/18
11/29
07:39
11/29/18
07:39
Periodicals
Insuers could pose challenge to Alkermes' 'good news,' STATNews reports »

Alkermes said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 02

    Dec

  • 31

    Jan

ALKS

Alkermes

$36.87

1.48 (4.18%)

07:32
11/29/18
11/29
07:32
11/29/18
07:32
Hot Stocks
Breaking Hot Stocks news story on Alkermes »

Alkermes rallies 6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 02

    Dec

  • 31

    Jan

ALKS

Alkermes

$36.87

1.48 (4.18%)

07:30
11/29/18
11/29
07:30
11/29/18
07:30
Hot Stocks
Breaking Hot Stocks news story on Alkermes 

Alkermes trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 02

    Dec

  • 31

    Jan

ALKS

Alkermes

$36.87

1.48 (4.18%)

07:26
11/29/18
11/29
07:26
11/29/18
07:26
Conference/Events
Alkermes to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 02

    Dec

  • 31

    Jan

ALKS

Alkermes

$36.87

1.48 (4.18%)

07:05
11/29/18
11/29
07:05
11/29/18
07:05
Hot Stocks
Alkermes to submit NDA for ALKS 3831 in mid-2019 »

With the successful…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 31

    Jan

ALKS

Alkermes

$36.87

1.48 (4.18%)

07:04
11/29/18
11/29
07:04
11/29/18
07:04
Hot Stocks
Alkermes reports schizophrenia Phase 3 trial met both co-primary endpoints »

Alkermes announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 31

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.